Trials / Active Not Recruiting
Active Not RecruitingNCT05254795
Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 659 (actual)
- Sponsor
- Timothy Mullett · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
This trial will compare Molecular Tumor Board (MTB) assisted care to usual care for patients who have newly diagnosed histologically or cytologically confirmed stage IIb-IV Non-Small Cell Lung Cancer (NSCLC) and are planning to undergo treatment for their cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Molecular tumor board assisted care | Participants in this group will obtain recommendations for care from the molecular tumor board. |
Timeline
- Start date
- 2022-04-13
- Primary completion
- 2026-12-22
- Completion
- 2026-12-22
- First posted
- 2022-02-24
- Last updated
- 2026-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05254795. Inclusion in this directory is not an endorsement.